T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

1. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    10

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 20 holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD, where the largest holding is Apple (9.72), followed by Microsoft (9.66) and Nvidia (8.48). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD and UBS Lux Equity Fund Biotech USD.

T. Rowe Price US Large Cap Growth Equity Fund A USD UBS Lux Equity Fund Biotech USD
1. Apple Inc
USA
9.72 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Microsoft Corp
USA
9.66 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Nvidia Corp
USA
8.48 %
3. Moderna Inc
9.21 %
4. Amazon.com Inc
USA
7.9 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Alphabet Inc Class A
USA
4.7 %
5. AbbVie Inc
USA
5.53 %
6. Meta Platforms A
USA
4.66 %
6. Gilead Sciences Inc
USA
4.66 %
7. Mastercard Inc
USA
3.72 %
7. Amgen Inc
4.3 %
8. Intuit Inc
3.31 %
8. BioNTech SE
4.13 %
9. ServiceNow Inc
USA
2.9 %
9. Karuna Therapeutics Inc
3.75 %
10. Visa Inc
USA
2.77 %
10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 5, 2025.